Announced Tue, 30 Jun · 15:10 IST
Board meeting on Aug 14, 2026 to approve Q1 FY27 results
Results View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.5%1-day move
₹224.00
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.5+5.4+15.2+27.2+24.1+13.4+16.1———
Up moveDown movePending
AI summary
Samrat Pharmachem has informed BSE its Board will meet on August 14, 2026 at 2:00 PM at the Andheri West, Mumbai office. The meeting will consider and approve the unaudited financial results under Ind-AS for the quarter ended June 30, 2026. Results will be shared with exchanges and posted on the company website after the meeting concludes.
Likely market impact
Routine advance notice. Q1 results due Aug 14, 2026; watch for revenue and profit trends.